Magellan Health Appoints Darren Lehrich as Chief Investor Relations Officer
July 06 2020 - 5:30AM
Business Wire
Magellan Health, Inc. (NASDAQ: MGLN) today announced it has
appointed Darren Lehrich as chief investor relations officer of
Magellan Health. Lehrich will lead a comprehensive, investor
relations program as Magellan expands relationships within key
financial communities and communicates the company’s strategic
direction, key initiatives and accomplishments.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200706005128/en/
Darren Lehrich (Photo: Business Wire)
Lehrich takes on the role formerly held by Joe Bogdan. As the
company invests in its growth strategy, Bogdan will continue his
focus leading the Actuarial and Underwriting team and expand his
responsibilities to include Medical Economics and Analytics in
support of the company’s strategic priorities and growth
initiatives.
“Darren is a highly respected leader who brings a solid track
record in investor relations to Magellan,” said Ken Fasola, chief
executive officer, Magellan Health. “He will be instrumental in
collaborating with the executive leadership team to drive a
dialogue that strengthens stakeholder understanding of the
company’s goal to become a leading independent payer services
partner, offering comprehensive and integrated complex care
services, solutions and insights across behavioral health,
specialty health and pharmacy.”
“I look forward to drawing on my experience and relationships
across the capital markets and the healthcare sector as we focus on
advancing the company’s next phase of growth and success,” said
Lehrich.
Before joining Magellan, Lehrich served as senior vice
president, Strategy and Investor Relations for American Renal
Associates Holdings, Inc. Prior to this role, his career spanned 17
years as an equity research analyst for several leading Wall Street
investment banks covering healthcare services companies. Earlier in
his career, Lehrich worked at Memorial Sloan-Kettering Cancer
Center, and he also completed administrative residencies at other
regional healthcare systems. Lehrich holds a master’s degree in
Finance from the Krannert School of Management at Purdue University
and a bachelor of science in Healthcare Policy and Administration
from Pennsylvania State University.
About Magellan Health: Magellan Health, Inc., a Fortune
500 company, is a leader in managing the fastest growing, most
complex areas of health, including special populations, complete
pharmacy benefits and other specialty areas of healthcare. Magellan
supports innovative ways of accessing better health through
technology, while remaining focused on the critical personal
relationships that are necessary to achieve a healthy, vibrant
life. Magellan's customers include health plans and other managed
care organizations, employers, labor unions, various military and
governmental agencies and third-party administrators. For more
information, visit MagellanHealth.com.
Forward-Looking Statements
This press release includes statements which may constitute
forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995,
the accuracy of which are necessarily subject to risks,
uncertainties, and assumptions as to future events that may not
prove to be accurate. These statements are neither promises nor
guarantees, but are subject to a variety of risks and
uncertainties, many of which are beyond our control, which could
cause actual results to differ materially from those contemplated
in these forward-looking statements. Existing and prospective
investors are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date hereof.
Factors that could cause actual results to differ materially from
those expressed or implied include the effectiveness of business
continuity plans during the COVID-19 pandemic, the possible
election of certain of the Company’s customers to manage the
healthcare services of their members directly; changes in rates
paid to and/or by the Company by customers and/or providers; higher
utilization of healthcare services by the Company’s members; risks
and uncertainties associated with the pharmacy benefits management
industry; delays, higher costs or inability to implement new
business or other Company initiatives; the impact of changes in the
contracting model for Medicaid contracts; termination or
non-renewal of customer contracts; the impact of new or amended
laws or regulations; governmental inquiries; litigation;
competition; operational issues; healthcare reform; and general
business conditions. Additional factors that could cause actual
results to differ materially from those reflected in the
forward-looking statements include, but are not limited to, the
risks discussed in the “Risk Factors” section included within the
Company’s most recent Annual Report on Form 10-K, quarterly report
on Form 10-Q, and subsequent reports on Forms 10-Q and 8-K. The
Company undertakes no obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise, except as may be required under
applicable securities law.
(MGLN-GEN)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200706005128/en/
Media Contact: Lilly Ackley, ackleyl@magellanhealth.com, (860)
507-1923 Investor Contact: Darren Lehrich,
lehrichd@magellanhealth.com, (917) 291-9311
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From Apr 2024 to May 2024
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From May 2023 to May 2024